Abstract
Purpose of Review: Describe the application of implementation science to improve the detection and management of familial hypercholesterolaemia. Recent Findings: Gaps between evidence and practice, such as underutilization of genetic testing, family cascade testing, failure to achieve LDL-cholesterol goals and low levels of knowledge and awareness, have been identified through clinical registry analyses and clinician surveys. Implementation science theories, models and frameworks have been applied to assess barriers and enablers in the literature specific to local contextual factors (e.g. stages of life). The effect of implementation strategies to overcome these factors has been evaluated; for example, automated identification of individuals with FH or training and education to improve statin adherence. Clinical registries were identified as a key infrastructure to monitor, evaluate and sustain improvements in care. Summary: The expansion in evidence supporting the care of familial hypercholesterolaemia requires a similar expansion of efforts to translate new knowledge into clinical practice.
Original language | English |
---|---|
Pages (from-to) | 133-143 |
Number of pages | 11 |
Journal | Current Atherosclerosis Reports |
Volume | 25 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2023 |
Bibliographical note
Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- Cholesterol
- Clinical practice guidelines
- Detection
- Familial hypercholesterolaemia
- Implementation science
- Statins